Cardiac Biomarker Diagnostic Kits Market Research Report by Disease (Angina Pectoris, Cardiac Heart Failure, and Myocardial Infraction), by Testing (Laboratory Testing and Point of Care Testing), by Product, by End User, by Region (Americas, Asia-Pacific,

Cardiac Biomarker Diagnostic Kits Market Research Report by Disease (Angina Pectoris, Cardiac Heart Failure, and Myocardial Infraction), by Testing (Laboratory Testing and Point of Care Testing), by Product, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Cardiac Biomarker Diagnostic Kits Market size was estimated at USD 2,954.11 million in 2020 and expected to reach USD 3,202.28 million in 2021, at a CAGR 8.73% to reach USD 4,883.68 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Cardiac Biomarker Diagnostic Kits to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease, the market was studied across Angina Pectoris, Cardiac Heart Failure, and Myocardial Infraction.

Based on Testing, the market was studied across Laboratory Testing and Point of Care Testing.

Based on Product, the market was studied across BNP Test Kit, C-reactive Protein (HSCRP), CK-MB Test Kits, Myoglobin Test Kits, and Troponin Test Kits.

Based on End User, the market was studied across Clinics, Diagnostics Centers, and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Biomarker Diagnostic Kits Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Biomarker Diagnostic Kits Market, including Abbott Laboratories, Atlas Medical, Beckman Coulter Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Carlyle Group, Creative Diagnostics, Danaher Corporation, DiaSorin, F. Hoffmann-La Roche AG, Guangzhou Wondfo Biotech, Lepu Medical Technology (Beijing) Co., Ltd., Life Diagnostics, LSI Medience Corporation, MP Biomedicals India Pvt Ltd., PerkinElmer, Inc., Randox Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific, Inc, Tosoh Corporation, and Trivitron Healthcare Private Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiac Biomarker Diagnostic Kits Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Biomarker Diagnostic Kits Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Biomarker Diagnostic Kits Market?
4. What is the competitive strategic window for opportunities in the Global Cardiac Biomarker Diagnostic Kits Market?
5. What are the technology trends and regulatory frameworks in the Global Cardiac Biomarker Diagnostic Kits Market?
6. What is the market share of the leading vendors in the Global Cardiac Biomarker Diagnostic Kits Market?
7. What modes and strategic moves are considered suitable for entering the Global Cardiac Biomarker Diagnostic Kits Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing cases of cardiovascular diseases worldwide
5.2.2. Rising geriatric population and the consequent increase in the burden of chronic diseases
5.2.3. Developments in field of cardiac biomarker diagnostic
5.3. Restraints
5.3.1. Concerns related to sample collection and storage
5.4. Opportunities
5.4.1. Increase in R&D efforts for new developments
5.4.2. Growing trend of Point-of-care testing (POCT)
5.5. Challenges
5.5.1. Lack of supportive reimbursement policies
6. Cardiac Biomarker Diagnostic Kits Market, by Disease
6.1. Introduction
6.2. Angina Pectoris
6.3. Cardiac Heart Failure
6.4. Myocardial Infraction
7. Cardiac Biomarker Diagnostic Kits Market, by Testing
7.1. Introduction
7.2. Laboratory Testing
7.3. Point of Care Testing
8. Cardiac Biomarker Diagnostic Kits Market, by Product
8.1. Introduction
8.2. BNP Test Kit
8.3. C-reactive Protein (HSCRP)
8.4. CK-MB Test Kits
8.5. Myoglobin Test Kits
8.6. Troponin Test Kits
9. Cardiac Biomarker Diagnostic Kits Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostics Centers
9.4. Hospitals
10. Americas Cardiac Biomarker Diagnostic Kits Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Atlas Medical
14.3. Beckman Coulter Inc.
14.4. Becton, Dickinson, and Company
14.5. Bio-Rad Laboratories, Inc.
14.6. bioMérieux SA
14.7. Carlyle Group
14.8. Creative Diagnostics
14.9. Danaher Corporation
14.10. DiaSorin
14.11. F. Hoffmann-La Roche AG
14.12. Guangzhou Wondfo Biotech
14.13. Lepu Medical Technology (Beijing) Co., Ltd.
14.14. Life Diagnostics
14.15. LSI Medience Corporation
14.16. MP Biomedicals India Pvt Ltd.
14.17. PerkinElmer, Inc.
14.18. Randox Laboratories
14.19. Siemens Healthineers AG
14.20. Thermo Fisher Scientific, Inc
14.21. Tosoh Corporation
14.22. Trivitron Healthcare Private Limited
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2026
FIGURE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2020 VS 2026 (%)
FIGURE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2026
FIGURE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 21. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2026
FIGURE 23. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN (HSCRP), 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN (HSCRP), BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 34. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2026
FIGURE 36. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN (HSCRP), BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: SCORES
TABLE 52. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: BUSINESS STRATEGY
TABLE 53. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: PRODUCT SATISFACTION
TABLE 54. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: RANKING
TABLE 55. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 56. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: MERGER & ACQUISITION
TABLE 57. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: INVESTMENT & FUNDING
TABLE 60. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 61. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook